Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
Clinical trial NCT01928771 · COMPLETED
Trial details
- NCT number
- NCT01928771
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-19
- Primary completion
- 2016-04-05
- Enrollment
- 2681
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.